2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)

EUROPEAN HEART JOURNAL

卷 43, 期 38, 页码 3618-3731

OXFORD UNIV PRESS

Guidelines; Pulmonary hypertension; Pulmonary arterial hypertension; Chronic thrombo-embolic pulmonary hypertension; Left heart disease; Congenital heart disease; Lung disease; Connective tissue disease; Endothelin receptor antagonists; Phosphodiesterase type 5 inhibitors; Soluble guanylate cyclase stimulators; Prostacyclin analogues; Prostacyclin receptor agonists; Pulmonary endarterectomy; Balloon pulmonary angioplasty; Lung transplantation

Cardiac & Cardiovascular Systems